Plasma and platelet serotonin levels in familial Mediterranean fever

Clinical and Experimental Rheumatology

Volumn 25, Issue 4 SUPPL. 45, 2007, Pages

  Onat, Ahmet Mesut ^a,f   Özçakar, Levent ^b   Öztürk, Mehmet Akif ^c   Uçar, Gülberk ^b   Üreten, Kemal ^d   Dagli, Neslihan ^e   Kiraz, Sedat ^b   Ertenli, Ihsan ^b   Çalgüneri, Meral ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e BASKENT UNIVERSITY   (Turkey)

^f NONE   (Turkey)

Author keywords

FMF; Inflammation; Serotonin; SSRI

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; FIBRINOGEN; SEROTONIN; ACUTE PHASE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; THROMBOCYTE; CORRELATION ANALYSIS; FIBRINOGEN BLOOD LEVEL; GROUPS BY AGE; HEMATOLOGICAL PARAMETERS; HOSPITAL ADMISSION; INFORMED CONSENT; MOLECULAR MECHANICS; SEX DIFFERENCE; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; COLCHICINE; DRUG RESISTANCE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GOUT SUPPRESSANTS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 35448937670     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. KIRAZ S, ERTENLI I, ARICI M et al.: Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 1998; 16: 721-4.
2. BAGCI S, TOY B, TUZUN A et al.: Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 2004; 23: 333-7.
3. HAZNEDAROGLU S, OZTURK MA, SANCAK B et al.: Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. Clin Exp Rheumatol 2005; 23(Suppl. 38): S77-S80.
4. ERKEN E, GUNESACAR R, OZBEK S, KONCA K: Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 1996; 55: 852-5.
5. OZYILKAN E, SIMSEK H, TELATAR H: Tumor necrosis factor in familial Mediterranean fever. Am J Med 1992: 579-80.
6. NOTARNICOLA C, DIDELOT MN, SEGURET F, DEMAILLE J, TOUITOU I: Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 2002; 3: 43-5.
7. MEGE JL, DILSEN N, SANGUEDOLCE W et al.: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993; 20: 1544-9.
8. GERSHON MDS Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004; 20 (Suppl. 7): 3-14.
9. MULDER EJ, ANDERSON GM, KEMA IP, MINDERAA RB: Reactivity of whole blood serotonin. Biol Psychiatr 2002; 51: 266-8.
10. LESCH KP, WOLOZIN BL, MURPHY DL, REIDERER P: Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem 1993; 60: 2319-22.
11. ZELLER J, WEISSBARTH E, BARUTH B, MIELKE H, DEICHER H: Serotonin content of platelets in inflammatory rheumatic diseases. Correlation with clinical activity. Arthritis Rheum 1983; 26: 532-40.
12. PICHLER R, MASCHEK W, KRIEGLSTEINER S, RAML A, SCHMEKAL B, BERG J: Pro-inflammatory role of serotonin and interleukin-6 in arthritis and spondylo-arthropathies ± measurement of disease activity by bone scan and effect of steroids. Scand J Rheumatol 2002; 31: 41-3.
13. ALSTERGREN P, KOPP S: Pain and synovial fluid concentration of serotonin in arthritic temporomandibular joints. Pain 1997; 72: 137-43.
14. ALSTERGREN P, ERNBERG M, KOPP S, LUNDEBERG T, THEODORSSON E: TMJ pain in relation to circulating neuropeptide Y, serotonin, and interleukin-1 beta in rheumatoid arthritis. J Orofac Pain 1999; 13: 49-55.
15. VOOG U, ALSTERGREN P, ELIASSIN S, LEIBUR E, KALLIKORM R, KOPP S: Inflammatory mediators and radiographic changes in temporomandibular joints of patients with rheumatoid arthritis. Acta Odontol Scand 2003; 61: 57-64.
16. OZCAKAR L, ONAT AM, KAYMAK SU, URETEN K, AKINCI A: Selective serotonin reuptake inhibitors in familial Mediterranean fever: Are we treating depression or inflammation? Rheumatol Int 2005; 25: 319-20.
17. TOUBI E, GERSHONI-BARUCH R, KUTEN A: Cisplatin treatment triggers familial Mediterranean fever attacks. Tumori 2003; 89: 80-1.
18. LIVNEH A, LANGEVITZ P, ZEMER D et al.: Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1998; 41: 1516-7.
19. BEARCROFT CP, PERRETT D, FARTHING MJ: Postprandial plasma 5-hydroxytryptamine in diarrhea predominant irritable bowel syndrome: A pilot study. Gut 1998; 42: 42-6.
20. SCHMIDT LG, DUFEU P, HEINZ A, KUHN S, ROMMELSPACHER H: Serotonergic dysfunction in addiction: Effects of alcohol, cigarette smoking and heroin on platelet 5-HT content. Psychiatry. Res 1997; 72: 177-85.
21. HARBUZ MS, PERVEEN-GILL Z, LALIES MD, JESSOP DS, LIGHTMAN SL, CHOWDREY HS: The role of endogenous serotonin in adjuvant-induced arthritis in the rat. Br J Rheumatol 1996; 35: 112-6.
22. HARBUZ MS, MARTI O, LIGHTMAN SL, JESSOP DS: Alteration of central serotonin modifies onset and severity of adjuvant-induced arthritis in the rat. Br J Rheumatol 1998; 37: 1077-83.
23. KUBERA M, MAES M, KENIS G, KIM YK, LASON W: Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor and interleukin-6. Psychiatry Research 2005; 134: 251-8.
24. MUCK-SELER D, PIVAC N, SAGUD M, JAKOVLJEVIC M, MIHALJEVIC-PELES A: The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2002; 26: 1235-43.
25. MAURER-SPUREJ E, PITTENDREIGH C, SOLOMONS K: The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 2004; 91: 119-28.
26. NEUGER J, WISTEDT B, SINNER B, ABERGWISTEDT A, STAIN-MALMGREN R: The effect of citalopram treatment on platelet serotonin function in panic disorders. Int Clin Psychopharmacol 2000; 15: 83-91.
27. BLARDI P, DE LALLA A, LEO A et al.: Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients. J Clin Psychopharmacol 2000; 22: 131-6.
28. ONAT AM, OZTURK MA, OZCAKAR L et al.: Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever. Tohoku J Exp Med 2007; 211: 9-14.